Tabula Rasa Healthcare Inc (TRHC)
$55.00 1.57 (2.94%)
13:25 EDT TRHC Stock Quote Delayed 30 Minutes
Previous Close $53.43
Market Cap 1.10B
PE Ratio -1,375.00
Volume (Avg. Vol.) 144,797
Day's Range 51.93 - 55.00
52-Week Range 33.04 - 69.72
Dividend & Yield N/A (N/A)
TRHC Stock Predictions, Articles, and Tabula Rasa Healthcare Inc News
- From InvestorPlace
- From the Web
For investors looking for home run hits, these 15 heavily shorted stocks with huge short squeeze potential are worth a look.
These small-cap stocks could rise by 1,000% or more in the 2020s, making them some of the best stocks to buy for the next 10 years.
Tabula Rasa Healthcare Inc (NULL:TRHC) is one of the 785 companies in the GICS Health Care sector, and a constituent of the 24 company Health Care Technology GICS industry group within this sector. TRHC has a market value of $0.5 billion which is in the lower half of its industry group. Currently, the stock's Portfolio Grader ranking places it 5 among the 24 companies in this industry group, placing it among the leaders; among the sector leaders with a ranking of 77 among the 785 companies in the sector, and number 547 in the nearly 5,000 company Portfolio Grader universe.
Profitability analysis is used to measure the company’s ability to manage its revenues effectively and provide stunning returns to its investors.
13G and 13D filings are windows into activist investor activity. Today we look at American Asset Trust and 17 other filings
From Talk Markets
From Analyst Ratings
Today it was reported that the Chief Commercial Officer of GW Pharma (GWPH – Research Report), Darren Cline, exercised options to sell 150 GWPH shares for a total transaction value of $18.97K. Following this transaction Darren Cline’s holding in the company was decreased by 9% to a total of $682K. In addition to Darren Cline,
From Simply Wall St
A look at the shareholders of GW Pharmaceuticals plc (NASDAQ:GWPH) can tell us which group is most powerful. Institutions often own shares in more established companies, while it’s not unusual<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gwph/gw-pharmaceuticals/news/what-type-of-shareholder-owns-gw-pharmaceuticals-plcs-nasdaqgwph/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader